Inflammatory mediator and β-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E

Free Radical Biology and Medicine

Volumn 37, Issue 3, 2004, Pages 325-338

  Ayasolla, Kamesh ^a   Khan, Mushfiquddin ^a   Singh, Avtar K ^a,b   Singh, Inderjit ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

amyloid peptide; Amyloid peptide; A ; Alzheimer disease; CCAAT enhancer binding proteins; Ceramide; Free radicals; Inducible nitric oxide synthase; manganese superoxide dismutase; MnSOD; Reactive oxygen species; SM; sphingomyelin; Vitamin E

Indexed keywords

3 O METHYLSPHINGOMYELIN; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN[25-35]; AUTACOID; CERAMIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DICHLOROFLUORESCEIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE; PROTEIN C; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE INHIBITOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; GLIA CELL; HUMAN; HUMAN TISSUE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ASTROCYTES; BRAIN; CELLS, CULTURED; CERAMIDES; ENZYME INDUCTION; FREE RADICALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIOMA; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; REACTIVE OXYGEN SPECIES; SPHINGOMYELINS; TRANSCRIPTION FACTORS; VITAMIN E;

EID: 3042586648     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.04.007     Document Type: Article

References (50)

1. Akama K.T., Van Eldik L.J. Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism. J. Biol. Chem. 275:2000;7918-7924
2. Akama K.T., Albanese C., Pestell R.G., Van Eldik L.J. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an Nfkappa B-dependent mechanism. Proc. Natl. Acad. Sci. USA. 95:1998;5795-5800
3. Law A., Gauthier S., Quirion R. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res. Brain Res. Rev. 35:2001;73-96
4. Sheng J.G., Griffin W.S., Royston M.C., Mrak R.E. Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 24(4):1998;278-283
5. Behl C., Moosmann B. Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach. Free Radic. Biol. Med. 33:2002;182-191
6. Singh I., Pahan K., Khan M., Singh A.K. Cytokine-mediated induction of ceramide production is redox-sensitive: implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J. Biol. Chem. 273:1998;20354-20362
7. Pahan K., Dobashi K., Ghosh B., Singh I. Induction of the manganese superoxide dismutase gene by sphingomyelinase and ceramide. J. Neurochem. 73:1999;513-520
8. Pahan K., Sheikh F.G., Khan M., Namboodiri A.M., Singh I. Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. J. Biol. Chem. 273:1998;2591-2600
9. Packer L. Protective role of vitamin E in biological systems. Am. J. Clin. Nutr. 53:1991;1050S-1055S
10. McIntyre B.S., Briski K.P., Tirmenstein M.A., Fariss M.W., Gapor A., Sylvester P.W. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. Lipids. 35:2000;171-180
11. Sen C.K., Khanna S., Roy S., Packer L. Molecular basis of vitamin E action: tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells. J. Biol. Chem. 275:2000;13049-13055
12. Li Y., Liu L., Barger S.W., Mrak R.E., Griffin W.S. Vitamin E suppression of microglial activation is neuroprotective. J. Neurosci. Res. 66:2001;163-170
13. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1993;1676-1687
14. Feinstein D.L., Galea E., Cermak J., Chugh P., Lyandvert L., Reis D.J. Nitric oxide synthase expression in glial cells: suppression by tyrosine kinase inhibitors. J. Neurochem. 62:1994;811-814
15. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685
16. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489
17. Ganser A.L., Kerner A.L., Brown B.J., Davisson M.T., Kirschner D.A. A survey of neurological mutant mice. I. Lipid composition of myelinated tissue in known myelin mutants. Dev. Neurosci. 10:1988;99-122
18. Preiss J., Loomis C.R., Bishop W.R., Stein R., Niedel J.E., Bell R.M. Quantitative measurement of sn-1, 2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J. Biol. Chem. 261:1986;8597-8600
19. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65:1995;1740-1751
20. Brera B., Serrano A., de Ceballos M.L. β-amyloid peptides are cytotoxic to astrocytes in culture: a role for oxidative stress. Neurobiol. Dis. 7:2000;395-405
21. Mirra S.S., Hart M.N., Terry R.D. Making the diagnosis of Alzheimer's disease: a primer for practicing pathologists. Arch. Pathol. Lab. Med. 117:1993;132-144
22. Floyd R.A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222:1999;236-245
23. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 77:1994;817-827
24. Pahan K., Sheikh F.G., Namboodiri A.M., Singh I. N-Acetyl cysteine inhibits induction of no production by endotoxin- or cytokine-stimulated rat peritoneal macrophages, C6 glial cells and astrocytes. Free Radic. Biol. Med. 24:1998;39-48
25. Copani A., Melchiorri D., Caricasole A., Martini F., Sale P., Carnevale R., Gradini R., Sortino M.A., Lenti L., De Maria R., Nicoletti F. Beta-amyloid-induced synthesis of the ganglioside GD3 is a requisite for cell cycle reactivation and apoptosis in neurons. J. Neurosci. 22:2002;3963-3968
26. Arenz C., Thutewohl M., Block O., Waldmann H., Altenbach H.J., Giannis A. Manumycin A and its analogues are irreversible inhibitors of neutral sphingomyelinase. Chembiochem. 2(2):2001;141-143
27. Mansat V., Bettaieb A., Levade T., Laurent G., Jaffrezou J.P. Serine protease inhibitors block neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. FASEB J. 11(8):1997;695-702
28. Hara M., Akasaka K., Akinaga S., Okabe M., Nakano H., Gomez R., Wood D., Uh M., Tamanoi F. Identification of Ras farnesyltransferase inhibitors by microbial screening. Proc. Natl. Acad. Sci. USA. 90:1993;2281-2285
29. Edwards K.M., Kam C.M., Powers J.C., Trapani J.A. The human cytotoxic T cell granule serine protease granzyme H has chymotrypsin-like (chymase) activity and is taken up into cytoplasmic vesicles reminiscent of granzyme B-containing endosomes. J. Biol. Chem. 274(43):1999;30468-30473
30. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720
31. Lee J.K., Choi S.S., Won J.S., Suh H.W. The regulation of inducible nitric oxide synthase gene expression induced by lipopolysaccharide and tumor necrosis factor-alpha in C6 cells: involvement of AP-1 and NFkappaB. Life Sci. 73(5):2003;595-609
32. Giri S., Jatana M., Rattan R., Won J.S., Singh I., Singh A.K. Galactosylsphingosine (psychosine)-induced expression of cytokine-mediated inducible nitric oxide synthases via AP-1 and C/EBP: implications for Krabbe disease. FASEB J. 16(7):2002;661-672
33. Gutierrez S., Javed A., Tennant D.K., van Rees M., Montecino M., Stein G.S., Stein J.L., Lian J.B. CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J. Biol. Chem. 277:2002;1316-1323
34. Gilgun-Sherki Y., Melamed E., Offen D. Oxidative stress-induced neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology. 40:2001;959-975
35. Zemlan F.P., Thienhaus O.J., Bosmann H.B. Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation. Brain Res. 476:1989;160-162
36. Frautschy S.A., Baird A., Cole G.M. Effects of injected Alzheimer beta-amyloid cores in rat brain. Proc. Natl. Acad. Sci. USA. 88:1991;8362-8366
37. Hannun Y.A., Obeid L.M. The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J. Biol. Chem. 277(29):2002;25847-25850
38. Smith W.L., Merrill A.H. Jr. Sphingolipid metabolism and signaling minireview series. J. Biol. Chem. 277(29):2002;25841-25842
39. Brugg B., Michel P.P., Agid Y., Ruberg M. Ceramide induces apoptosis in cultured mesencephalic neurons. J. Neurochem. 66(2):1996;733-739
40. Wiesner D.A., Dawson G. Programmed cell death in neurotumour cells involves the generation of ceramide. Glycoconjugate J. 13:1996;327-333
41. Hannun Y.A., Luberto C. Ceramide in the eukaryotic stress response. Trends Cell Biol. 10(2):2000;73-80
42. Kim H.J., Lee K.J. Heat shock and ceramide have different apoptotic pathways in radiation induced fibrosarcoma (RIF) cells. Mol. Cell. Biochem. 229(1-2):2002;139-1351
43. Rodriguez-Lafrasse C., Alphonse G., Aloy M.T., Ardail D., Gerard J.P., Louisot P., Rousson R. Increasing endogenous ceramide using inhibitors of sphingolipid metabolism maximizes ionizing radiation-induced mitochondrial injury and apoptotic cell killing. Int. J. Cancer. 101(6):2002;589-598
44. 2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J. Biol. Chem. 271(14):1996;8307-8312
45. Cotrina M.L., Nedergaard M. Astrocytes in the aging brain. J. Neurosci. Res. 67:2002;1-10
46. Puglielli L., Ellis B.C., Saunders A.J., Kovacs D.M. Ceramide stabilizes {beta}-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid {beta}-peptide biogenesis. J. Biol. Chem. 278(22):2003;19777-19783
47. Azzi A., Ricciarelli R., Zingg J.M. Non-antioxidant molecular functions of alpha-tocopherol (vitamin E). FEBS Lett. 519(1-3):2002;8-10
48. Hara H., Kato H., Kogure K. Protective effect of alpha-tocopherol on ischemic neuronal damage in the gerbil hippocampus. Brain Res. 510(2):1990;335-338
49. Grundman M. Vitamin E and Alzheimer disease: the basis for additional clinical trials. Am. J. Clin. Nutr. 71(2):2000;630S-636S
50. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336(17):1997;1216-1222